Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAIR-i: Effect of colchicine on food-related effort-based decision making in overweight and obesity
2021-004919-11Phase 4Completed
- Sponsor
- Donders Institute for Brain, Cognition and Behaviour
- Start
- Jan 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in obesity and inflammation comparing Colchicine with Placebo (2 arms). Primary endpoints: Brain activity during effort-based decision making and Behavioural weightings of effort and reward valuation. Started Jan 2022; status: completed.
02
Drugs
colchicine
03
Conditions
obesityinflammation
Beyond the preview
Go deeper on 2021-004919-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-004919-11.